The biocontrol potential of Streptomyces polychromogenes YKL‐11 against apple replant disease: Inhibition of the growth of pathogenic Fusarium and remodelling of soil microbial flora
Plant Biology · 2026
DOI: 10.1111/plb.70243 ↗Kurz gefasst
Fachartikel in der Zeitschrift Plant Biology, 2026. Verfasst von X Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Horticultural Science and Engineering, Shandong Agricultural University, Tai'an City, Shandong, China. Hauptthemen laut MEDLINE: Fusarium, Malus, Streptomyces, Soil Microbiology. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Key Technology Research and Development Program of Shandong Province, China Agriculture Research System of Ministry of Finance and Ministry of Agriculture and Rural Affairs, Taishan Scholar Funded Project.
Abstract (Originalsprache)
Apple replant disease (ARD) severely restricts the sustainable development of the apple industry. Streptomyces is important for the development of biocontrol bacteria for plant diseases and has broad prospects for use in agriculture. This study focused on Fusarium , one of the main pathogens involved in the development of ARD. The antagonistic strain Streptomyces polychromogenes YKL‐11 was isolated from the rhizosphere soil of healthy apple trees in old orchards. High‐throughput sequencing was used to investigate the effects of YKL‐11 on the microbial community in replanted soil, and its biocontrol efficacy was evaluated through pot and field experiments. YKL‐11 can significantly erode and disrupt the mycelial structure of Fusarium , causing its spores to atrophy and deform, thereby efficiently inhibiting the growth of this fungus. The results of the pot experiment showed that the application of YKL‐11 could significantly promote the growth of apple seedlings, while effectively reducing the soil population of Fusarium oxysporum , F. moniliforme , F. solani and F. proliferatum . A microbiome analysis revealed that YKL‐11 optimizes the microbial community. Composition in replanted soil by enriching beneficial genera such as Chaetomium and Trichoderma while inhibiting harmful genera, including Fusarium , Cephalotrichum and Neocosmospora . Overall, S. polychromogenes YKL‐11 can effectively alleviate ARD. The results of this study provide a new theoretical basis and practical ideas for the green biological control of ARD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Horticultural Science and Engineering, Shandong Agricultural University, Tai'an City, Shandong, China.
ORCID-Profile: Z Mao
Förderung
- Key Technology Research and Development Program of Shandong Province
- China Agriculture Research System of Ministry of Finance and Ministry of Agriculture and Rural Affairs
- Taishan Scholar Funded Project
- Key R&D program of Shandong Province
- National Key Research and Development Program of China
- The National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China
Zitieren
APA
Li, X., Lv, J., Zhao, L., Chang, Q., Zhao, K., Chen, X., Liu, Y., Yin, C., & Mao, Z. (2026). The biocontrol potential of Streptomyces polychromogenes YKL‐11 against apple replant disease: Inhibition of the growth of pathogenic Fusarium and remodelling of soil microbial flora. Plant Biology. https://doi.org/10.1111/plb.70243
Vancouver
Li X, Lv J, Zhao L, Chang Q, Zhao K, Chen X, et al. The biocontrol potential of Streptomyces polychromogenes YKL‐11 against apple replant disease: Inhibition of the growth of pathogenic Fusarium and remodelling of soil microbial flora. Plant Biology. 2026. doi:10.1111/plb.70243
BibTeX
@article{Li2026,
author = {Li, X and Lv, J and Zhao, L and Chang, Q and Zhao, K and Chen, X and Liu, Y and Yin, C and Mao, Z},
title = {The biocontrol potential of Streptomyces polychromogenes YKL‐11 against apple replant disease: Inhibition of the growth of pathogenic Fusarium and remodelling of soil microbial flora},
journal = {Plant Biology},
year = {2026},
doi = {10.1111/plb.70243}
}
EUVIMED